ECM
RVMD icon

Everence Capital Management’s Revolution Medicines RVMD Stock Holding History

Everence Capital Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$525K Buy
5,402
+772
+17% +$78K 0.03% 364
2025
Q4 		$369K Hold
4,630
– – 0.02% 508
2025
Q3 		$216K Buy
+4,630
New +$181K 0.01% 743
2025
Q1 		– Sell
-4,630
Closed -$203K – 833
2024
Q4 		$203K Buy
+4,630
New +$234K 0.01% 779

Other funds holding RVMD

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Everence Capital Management's RVMD Position: Q1 2026 in Review

Everence Capital Management increased its Revolution Medicines (RVMD) stake by 17% in Q1 2026, buying an estimated $78K and bringing the position to 5,402 shares worth $525K. The position accounts for 0.03% of the portfolio, ranked #364.

Everence Capital Management first reported a position in RVMD in Q4 2024 and has held it in 4 quarters since. 512 funds tracked by Wall St. Rank hold RVMD as of Q1 2026.

  • Everence Capital Management held 5,402 shares of Revolution Medicines worth $525K as of Q1 2026.
  • Everence Capital Management bought 772 Revolution Medicines shares in Q1 2026, an estimated $78K.
  • Revolution Medicines made up 0.03% of Everence Capital Management's portfolio in Q1 2026, its #364 holding.
  • Everence Capital Management first reported a position in Revolution Medicines in Q4 2024 and has held it in 4 quarters since.
  • 512 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2026.

Based on Everence Capital Management's 13F filing for Q1 2026, filed 28 Apr 2026.